{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:33:38Z","timestamp":1780090418798,"version":"3.54.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.drudis.2020.06.017","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:50:09Z","timestamp":1592661009000},"page":"1535-1544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Discovering small-molecule therapeutics against SARS-CoV-2"],"prefix":"10.1016","volume":"25","author":[{"given":"Vaibhav","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehru Viji","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Swanson-Mungerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.06.017_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.06.017_bib0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.drudis.2020.06.017_bib0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: a model-based analysis","volume":"20","author":"Verity","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2020.06.017_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2020.06.017_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.06.017_bib0035","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.drudis.2020.06.017_bib0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.06.017_bib0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nsmb.3293","article-title":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy","volume":"23","author":"Walls","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0060","first-page":"13","article-title":"Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)","volume":"31","author":"Kumar","year":"2020","journal-title":"Virus Dis"},{"key":"10.1016\/j.drudis.2020.06.017_bib0065","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwaa042","article-title":"Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2","author":"Shajahan","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.drudis.2020.06.017_bib0070","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drudis.2020.06.017_bib0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0090","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0095","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4","volume":"88","author":"van Doremalen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0100","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1128\/JVI.00854-15","article-title":"Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2005.11.044","article-title":"Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated","volume":"347","author":"Butler","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2020.06.017_bib0110","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.drudis.2020.06.017_bib0115","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1128\/JVI.01094-08","article-title":"Utilization of DC-SIGN for entry of feline coronaviruses into host cells","volume":"82","author":"Regan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1083\/jcb.116.5.1273","article-title":"Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans","volume":"116","author":"Shieh","year":"1992","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0125","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/jhep.2000.18713","article-title":"Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes","volume":"32","author":"Hilgard","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2020.06.017_bib0130","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.1128\/JVI.79.22.14451-14456.2005","article-title":"Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor","volume":"79","author":"de Haan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0135","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.00717-09","article-title":"Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection","volume":"83","author":"Kalia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0140","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","article-title":"Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells","volume":"88","author":"Milewska","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0145","doi-asserted-by":"crossref","first-page":"e23710","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2020.06.017_bib0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3201\/eid1003.030683","article-title":"Coronaviridae and SARS-associated coronavirus strain HSR1","volume":"10","author":"Vicenzi","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.06.017_bib0155","article-title":"The 2019 coronavirus (SARS-CoV-2) surface protein (spike) S1 receptor binding domain undergoes conformational change upon heparin binding","author":"Mycroft-West","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.drudis.2020.06.017_bib0160","article-title":"Glycosaminoglycan binding motif at S1\/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry","author":"Kim","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.drudis.2020.06.017_bib0165","article-title":"SARS-CoV-2 spike protein binds heparan sulfate in a length and sequence-dependent manner","author":"Liu","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.drudis.2020.06.017_bib0170","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","article-title":"Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A","volume":"116","author":"Hulswit","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S.A."},{"key":"10.1016\/j.drudis.2020.06.017_bib0175","doi-asserted-by":"crossref","first-page":"e01815","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12916-016-0686-3","article-title":"Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV)","volume":"14","author":"Zumla","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.drudis.2020.06.017_bib0190","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1073\/pnas.1320856111","article-title":"Interferon induction of IFITM proteins promotes infection by human coronavirus OC43","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.06.017_bib0195","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","article-title":"Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion","volume":"90","author":"Coleman","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0200","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1242\/jcs.039859","article-title":"Regulation of cytoskeletal dynamics and cell morphogenesis by Abl family kinases: emerging mechanisms and physiological contexts","volume":"122","author":"Bradley","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2020.06.017_bib0205","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.3390\/v12020244","article-title":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","volume":"12","author":"Xu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2020.06.017_bib0210","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","article-title":"Recent discovery and development of inhibitors targeting coronaviruses","volume":"25","author":"Pillaiyar","year":"2020","journal-title":"Drug Disc. Today"},{"key":"10.1016\/j.drudis.2020.06.017_bib0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: a systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Ind. J. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.chembiol.2008.04.011","article-title":"A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters","volume":"15","author":"Verschueren","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0235","first-page":"2020","article-title":"Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach","volume":"13","author":"Khan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.drudis.2020.06.017_bib0240","first-page":"2020","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds","volume":"11","author":"Ton","year":"2020","journal-title":"Mol. Inform."},{"key":"10.1016\/j.drudis.2020.06.017_bib0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2017.05.045","article-title":"Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study","volume":"137","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.06.017_bib0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0255","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.06.017_bib0260","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jm401712t","article-title":"X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases","volume":"57","author":"B\u00e1ez-Santos","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.06.017_bib0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.drudis.2020.06.017_bib0275","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.06.017_bib0280","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.06.017_bib0285","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2020.06.017_bib0290","series-title":"NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19","author":"NIH","year":"2020"},{"key":"10.1016\/j.drudis.2020.06.017_bib0295","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2013.11.006","article-title":"SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets","volume":"101","author":"Subissi","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0305","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0310","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drudis.2020.06.017_bib0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.06.017_bib0320","doi-asserted-by":"crossref","first-page":"e7870","DOI":"10.1371\/journal.pone.0007870","article-title":"Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro","volume":"4","author":"Kam","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2020.06.017_bib0325","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0330","doi-asserted-by":"crossref","first-page":"11985","DOI":"10.1128\/JVI.01412-08","article-title":"Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein","volume":"82","author":"Watanabe","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0335","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2020.06.017_bib0340","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.drudis.2020.06.017_bib0345","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.06.017_bib0350","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2011.12.012","article-title":"A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2","volume":"94","author":"Struck","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0355","article-title":"The first-in-class peptide binder to the SARS-CoV-2 spike protein","author":"Zhang","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.drudis.2020.06.017_bib0360","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0365","doi-asserted-by":"crossref","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","article-title":"Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo","volume":"286","author":"Tiwari","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2020.06.017_bib0370","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/JVI.00433-12","article-title":"A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells","volume":"86","author":"Ali","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0375","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1099\/0022-1317-82-10-2405","article-title":"Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and\/or entry stimulates the expression of human leukocyte antigen class I","volume":"82","author":"Song","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0380","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/JVI.00109-15","article-title":"A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells","volume":"89","author":"Baldwin","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0385","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1021\/bi800205t","article-title":"Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1","volume":"47","author":"Copeland","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2020.06.017_bib0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.sbi.2017.12.004","article-title":"So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again!","volume":"50","author":"Sankaranarayanan","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2018.11.007","article-title":"A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells","volume":"161","author":"Majmudar","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0400","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/ijms21051676","article-title":"Inhibition of human cytomegalovirus entry into host cells through a pleiotropic small molecule","volume":"21","author":"Elste","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drudis.2020.06.017_bib0405","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect"},{"key":"10.1016\/j.drudis.2020.06.017_bib0410","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.03999-14","article-title":"Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2","volume":"59","author":"Zhao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2020.06.017_bib0415","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.drudis.2020.06.017_bib0420","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles","volume":"82","author":"Siu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0425","doi-asserted-by":"crossref","first-page":"e1000511","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2020.06.017_bib0430","doi-asserted-by":"crossref","first-page":"32340","DOI":"10.1038\/srep32340","article-title":"Broad spectrum anti-influenza agents by inhibiting self-association of matrix protein 1","volume":"6","author":"Mosier","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.06.017_bib0435","doi-asserted-by":"crossref","first-page":"e105114","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2020.06.017_bib0440","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0445","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.06.017_bib0450","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1091\/mbc.e16-05-0292","article-title":"Abelson kinase acts as a robust, multifunctional scaffold in regulating embryonic morphogenesis","volume":"27","author":"Rogers","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drudis.2020.06.017_bib0455","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2020.06.017_bib0460","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors","volume":"99","author":"Sisk","year":"2018","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drudis.2020.06.017_bib0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0470","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Disc."},{"key":"10.1016\/j.drudis.2020.06.017_bib0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.drudis.2020.06.017_bib0480","doi-asserted-by":"crossref","first-page":"129","DOI":"10.12688\/f1000research.22457.2","article-title":"Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates","volume":"9","author":"Chen","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.drudis.2020.06.017_bib0485","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets of SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sinica B"},{"key":"10.1016\/j.drudis.2020.06.017_bib0490","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2020.06.017_bib0495","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543776.2013.823159","article-title":"Anti-SARS coronavirus agents: a patent review (2008\u2013present)","volume":"23","author":"Kumar","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.drudis.2020.06.017_bib0500","article-title":"In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel","author":"Gupta","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.drudis.2020.06.017_bib0505","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/d41586-018-05267-x","article-title":"How artificial intelligence is changing drug discovery","volume":"557","author":"Fleming","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.06.017_bib0510","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1038\/ncomms7985","article-title":"Heparanase is a host enzyme required for herpes simplex virus-1 release from cells","volume":"6","author":"Hadigal","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620302452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620302452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:46:39Z","timestamp":1761223599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620302452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":102,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1359644620302452"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.06.017","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovering small-molecule therapeutics against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}